pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
590
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
obefazimod
Ulcerative Colitis
Cap binding complex
Abivax SA
0
catalysts
Phase 3
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
B-lymphocyte antigen CD19
Low affinity immunoglobulin gamma Fc region receptor II-b
$ZBIO
Zenas BioPharma, Inc.
0
catalysts
Phase 3
obicetrapib calcium
← prev
page 15 of 20
next →
131
Pain
89
Neurology
1
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
0
catalysts
Phase 3
obudanersen sodium
Angelman Syndrome
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Phase 3
ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Celltrion Inc
0
catalysts
Phase 3
odronextamab
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
B-lymphocyte antigen CD20
T cell surface glycoprotein CD3
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 3
olomorasib
Non-Small Cell Lung Cancer
Eli Lilly and Co
0
catalysts
Phase 3
olpasiran
Atherosclerosis
LPA mRNA
$AMGN
AMGEN INC
0
catalysts
Phase 3
olverembatinib
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Bcr/Abl fusion protein
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
0
catalysts
Phase 3
olvimulogene nanivacirepvec
Endometrial Cancer
$GNLX
GENELUX Corp
0
catalysts
Phase 3
omidubicel
Omisirge (omidubicel-onlv)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Gamida Cell Ltd
0
catalysts
Phase 3
onfekafusp alfa
onfekafusp alfa [INN]
Soft Tissue Sarcoma
Philogen SpA
0
catalysts
Phase 3
onvuzosiran sodium
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
ADARx Pharmaceuticals Inc
0
catalysts
Phase 3
opiranserin
opiranserin [INN]
Post-Operative Pain
Vivozon Inc
0
catalysts
Phase 3
oregovomab
Ovarex (oregovomab)
Fallopian Tube Cancer
Mucin-16
OncoQuest Inc
0
catalysts
Phase 3
orelabrutinib
Primary Progressive Multiple Sclerosis (PPMS)
Tyrosine-protein kinase BTK
$ZBIO
Zenas BioPharma, Inc.
0
catalysts
Phase 3
osivelotor
Sickle Cell Disease
$PFE
PFIZER INC
0
catalysts
Phase 3
oxytocin
Pitocin (oxytocin [INN])
Prader-Willi Syndrome (PWS)
OT4B
0
catalysts
Phase 3
pabinafusp alfa
pabinafusp alfa [INN]
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
JCR Pharmaceuticals Co Ltd
0
catalysts
Phase 3
padeliporfin potassium
Transitional Cell Cancer (Urothelial Cell Cancer)
ImPact Biotech Limited
0
catalysts
Phase 3
palazestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$OLMA
Olema Pharmaceuticals, Inc.
0
catalysts
Phase 3
paridiprubart
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
$EDSA
Edesa Biotech, Inc.
0
catalysts
Phase 3
paromomycin
Paromomycin Sulfate (paromomycin [INN])
Leishmaniasis
Appili Therapeutics Inc
0
catalysts
Phase 3
pasritamig
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 3
patidegib hydrochloride
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndr…
$SLGL
Sol-Gel Technologies Ltd.
0
catalysts
Phase 3
patritumab deruxtecan
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Receptor tyrosine-protein kinase erbB-3
DNA topoisomerase 1
Daiichi Sankyo Co Ltd
0
catalysts
Phase 3
paxalisib
Recurrent Glioblastoma Multiforme (GBM)
PI3-kinase class I
$KZIA
KAZIA THERAPEUTICS LTD
0
catalysts
Phase 3
peginterferon lambda-1a
Coronavirus Disease 2019 (COVID-19)
Interferon lambda receptor
Eiger Inno Therapeutics Inc
0
catalysts
Phase 3
pegozafermin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
89bio Inc
0
catalysts
Phase 3
pegtibatinase
Homocystinuria
$TVTX
Travere Therapeutics, Inc.
0
catalysts